SEC Form 4 · accession 0001179110-18-011083
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph H Boccuzi
Director
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001F1,F2 | Aug 30, 2018 | P | 900 | $190.59 | A | 3,885 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $190.58 to $190.59, inclusive.
- F2Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.